Epinephrine-Lidocaine HCl 0 — Class III drug recall D-0478-2024
Ongoing recall by Imprimis NJOF, LLC, reported 2024-05-08, distributed nationwide. Out of specification for assay
| Recall number | D-0478-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Imprimis NJOF, LLC, Ledgewood, NJ, United States |
| Recall initiated | 2024-04-10 |
| Classified | 2024-04-30 |
| Reported by FDA | 2024-05-08 |
| Distributed | Nationwide (US) |
| Quantity | 15,414 units |
| Reason classes | potency, specification failure |
| NDC | 71384-0640-01 |
| Lot numbers | 23AUG053, 23JUL028 |
| Expiration dates | 2024-08-01, 2024-08-30 |
Product
Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC 71384-640-01
Reason for recall
Out of specification for assay
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0478-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.